EU to buy $478 million WHO COVID-19 vaccine for low and middle income countries
The European Commission said that the financial support will be provided through guarantees.
The European Commission said that the financial support will be provided through guarantees.
The vaccine is said to be undergoing Phase 3 trials, which is the final stage.
WHO urged governments and citizens to focus on known basic steps to contain the pandemic.
The committee expects the COVID-19 to remain a public health emergency of international concern.
The vaccine is being developed by Russia’s Gamaleya Institute and the Russian Direct Investment Fund.
The updated travel advice contains minor changes from previous guidance.
Moderna has already begun experimental testing on humans.
WHO has been working to expand access to potential vaccines and scale up production capacity.
Africa had over 663,000 confirmed COVID-19 cases, 343,000 recoveries and 14,000 deaths.
The human trials of the Oxford vaccine are expected to be through in September.